Stock PGNY PROGYNY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Progyny, Inc.

Equities

PGNY

US74340E1038

Managed Healthcare

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
27 USD -0.55% Intraday chart for Progyny, Inc. -3.88% -27.38%
May. 23 Transcript : Progyny, Inc. - Shareholder/Analyst Call
May. 22 Progyny Gets Board Approval for $100 Million Share Repurchase Program; Stock Rises After Hours MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,307 3,672 4,553 2,893 3,563 2,571 - -
Enterprise Value (EV) 1 2,227 3,672 4,434 2,773 3,466 2,302 2,091 1,834
P/E ratio -67 x 90.2 x 76.3 x 104 x 60 x 37.4 x 27.7 x 27.8 x
Yield - - - - - - - -
Capitalization / Revenue 10 x 10.6 x 9.1 x 3.68 x 3.27 x 2.08 x 1.76 x 1.55 x
EV / Revenue 9.69 x 10.6 x 8.86 x 3.52 x 3.18 x 1.86 x 1.43 x 1.11 x
EV / EBITDA 121 x 113 x 65.8 x 22.1 x 18.5 x 10.6 x 7.92 x 6.02 x
EV / FCF -496 x 104 x 185 x 35.9 x 18.7 x 14.2 x 9.59 x 6.77 x
FCF Yield -0.2% 0.96% 0.54% 2.78% 5.34% 7.02% 10.4% 14.8%
Price to Book 20.2 x - 18.2 x 8.26 x 6.47 x 3.58 x 2.8 x 2.25 x
Nbr of stocks (in thousands) 84,046 86,634 90,430 92,883 95,836 95,221 - -
Reference price 2 27.45 42.39 50.35 31.15 37.18 27.00 27.00 27.00
Announcement Date 3/5/20 2/24/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 229.7 344.9 500.6 786.9 1,089 1,236 1,463 1,659
EBITDA 1 18.34 32.39 67.35 125.7 187.1 216.6 264.2 304.7
EBIT 1 16.21 8.348 32.34 23.34 62.18 212.6 261.4 -
Operating Margin 7.06% 2.42% 6.46% 2.97% 5.71% 17.2% 17.87% -
Earnings before Tax (EBT) 1 - 8.679 32.44 24.44 70.69 103.5 143.2 -
Net income 1 -8.569 46.46 65.77 30.36 62.04 72.28 98.82 101.4
Net margin -3.73% 13.47% 13.14% 3.86% 5.7% 5.85% 6.75% 6.11%
EPS 2 -0.4100 0.4700 0.6600 0.3000 0.6200 0.7211 0.9746 0.9699
Free Cash Flow 1 -4.49 35.17 23.91 77.15 185.2 161.7 218 271
FCF margin -1.95% 10.2% 4.78% 9.8% 17.01% 13.08% 14.9% 16.33%
FCF Conversion (EBITDA) - 108.56% 35.5% 61.38% 98.98% 74.66% 82.53% 88.95%
FCF Conversion (Net income) - 75.69% 36.35% 254.15% 298.48% 223.73% 220.61% 267.19%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/5/20 2/24/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 127.6 172.2 195 205.4 214.3 258.4 279.4 280.9 269.9 278.1 308 327.3 323.9 342.6 378.9
EBITDA 1 15.14 24.81 32.88 34.96 33.05 46.36 47.46 50.02 43.23 50.29 54.86 58.51 55.12 60.71 66.86
EBIT 1 -0.188 -0.058 8.838 11.26 3.306 45.82 46.94 49.44 13.8 49.58 53.09 56.54 53.38 60.01 66.08
Operating Margin -0.15% -0.03% 4.53% 5.48% 1.54% 17.73% 16.8% 17.6% 5.11% 17.83% 17.24% 17.28% 16.48% 17.52% 17.44%
Earnings before Tax (EBT) 1 -0.398 -0.142 8.903 11.54 4.141 16.33 17.17 20.93 16.26 22.52 22.68 26.19 25.44 33.47 37.41
Net income 1 15.08 4.971 8.768 13.21 3.408 17.68 14.99 15.9 13.47 16.9 17.16 19.91 18.75 25.05 28.18
Net margin 11.82% 2.89% 4.5% 6.43% 1.59% 6.84% 5.37% 5.66% 4.99% 6.08% 5.57% 6.08% 5.79% 7.31% 7.44%
EPS 2 0.1500 0.0500 0.0900 0.1300 0.0300 0.1800 0.1500 0.1600 0.1300 0.1700 0.1726 0.2013 0.1831 0.2373 0.2560
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/28/22 5/5/22 8/5/22 11/3/22 2/27/23 5/8/23 8/3/23 11/7/23 2/27/24 5/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 80.4 - 119 120 97.3 269 480 737
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -4.49 35.2 23.9 77.2 185 162 218 271
ROE (net income / shareholders' equity) - 12.7% 31.4% 9.66% 13.3% 26.1% 20.9% 19.1%
ROA (Net income/ Total Assets) 10% - 21.5% 29.1% 9.55% 18.8% 16.4% 15.2%
Assets 1 -85.52 - 306 104.3 649.8 383.6 604.3 665.7
Book Value Per Share 2 1.360 - 2.760 3.770 5.740 7.530 9.630 12.00
Cash Flow per Share 2 -0.0700 0.3700 0.2600 0.8000 1.880 2.020 2.290 -
Capex 1 2.96 - 2.13 3.24 3.64 4 5 5
Capex / Sales 1.29% - 0.43% 0.41% 0.33% 0.32% 0.34% 0.3%
Announcement Date 3/5/20 2/24/21 2/28/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Progyny, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
27 USD
Average target price
38.56 USD
Spread / Average Target
+42.80%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

1st Jan change Capi.
PROGYNY, INC. Stock Progyny, Inc.
-27.38% 2.57B
UNITEDHEALTH GROUP INC. Stock UnitedHealth Group Inc.
-3.48% 468B
CIGNA Stock Cigna
+11.07% 94.49B
HUMANA INC. Stock Humana Inc.
-23.70% 42.09B
CENTENE CORPORATION Stock Centene Corporation
+0.57% 39.83B
MOLINA HEALTHCARE, INC. Stock Molina Healthcare, Inc.
-8.08% 19.46B
ALIGNMENT HEALTHCARE, INC. Stock Alignment Healthcare, Inc.
-16.84% 1.37B
CLOVER HEALTH INVESTMENTS, CORP. Stock Clover Health Investments, Corp.
+5.03% 496M
Other Managed Healthcare
  1. Stock Market
  2. Equities
  3. PGNY Stock
  4. Financials Progyny, Inc.